The Captopril Prevention Project (CAPPP): description and status

Abstract

The Captopril Prevention Project (CAPPP) is an ongoing prospective intervention study in 10,800 hypertensive patients in Sweden and Finland. Patients are randomized to treatment with either conventional antihypertensive therapy, ie, diuretics or beta-blockers, or the angiotensin-converting enzyme inhibitor captopril. The purpose of the CAPPP Study is to compare the two therapeutic alternatives with regard to cardiovascular mortality.